Millar Kerri-Ann 4
4 · Cue Biopharma, Inc. · Filed Aug 25, 2020
Insider Transaction Report
Form 4
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2020-08-24−1,900→ 5,766 total - Award
Restricted Stock Units
2020-08-21+20,000→ 20,000 total→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2020-08-21+6,666→ 7,666 total - Award
Stock Option (right to buy)
2020-08-21+65,000→ 65,000 totalExercise: $19.87Exp: 2030-08-21→ Common Stock (65,000 underlying) - Exercise/Conversion
Restricted Stock Units
2020-08-21−6,666→ 13,334 total→ Common Stock (6,666 underlying)
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]This stock option grant becomes exercisable in eight equal semi-annual installments beginning February 21, 2021.
- [F3]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F4]Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020.